IPOPLUS

6,663.5

-49 -0.73%

18 Jun 2026

NSE Listed · Pharmaceuticals

Divis Laboratories Ltd. (DIVISLAB)

Volume: 15,821Avg Vol 1W: 83,059Avg Vol 1M: 2,02,57052W Range:5,636.57,071.5
₹6,663.5 0.73%
Market Cap₹1,76,087 Cr
Current Price₹6,663.5
Previous Close₹6,712.5
High / Low (52w)₹7,071.5 / ₹5,636.5
Volume15,821
Avg Vol (1W)83,059
Avg Vol (1M)2,02,570
Stock P/E69.82
Book Value₹632.49
Dividend Yield0.45%
ROE15.32%
ROA12.82%
Revenue (TTM)
Revenue Growth19.31%
Profit Margin24.32%
Total Debt₹0 Cr
Shares Outstanding27 Cr
Face Value₹2
EPS (TTM)₹28.31
P/B10.62
Debt / Equity0
50 DMA₹6,718.91
200 DMA₹6,338.49
Day change-0.73%
Price Chart
6,663.5 0.92% · 1Y
6922581019.3L
2025-10-20
2026-06-16

20-day avg volume: 2.2L shares

Pros
  • Healthy return on equity of 15.3%.
  • Company is almost debt-free.
  • Revenue grew 19% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 70.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹2,831 Cr₹2,604 Cr₹2,715 Cr₹2,410 Cr₹2,585 Cr₹2,319 Cr₹2,338 Cr₹2,118 Cr₹2,303 Cr₹1,855 Cr₹1,909 Cr₹1,778 Cr₹1,951 Cr₹1,708 Cr₹1,855 Cr₹2,255 Cr₹2,518 Cr₹2,493 Cr₹1,988 Cr₹1,961 Cr₹1,788 Cr₹1,701 Cr₹1,749 Cr₹1,730 Cr₹1,390 Cr
EBITDA₹969 Cr₹860 Cr₹920 Cr₹736 Cr₹865 Cr₹726 Cr₹723 Cr₹604 Cr₹715 Cr₹489 Cr₹470 Cr₹492 Cr₹466 Cr₹435 Cr₹615 Cr₹852 Cr₹1,076 Cr₹1,034 Cr₹760 Cr₹815 Cr₹670 Cr₹642 Cr₹694 Cr₹661 Cr₹471 Cr
Net Profit₹751 Cr₹583 Cr₹689 Cr₹545 Cr₹662 Cr₹589 Cr₹510 Cr₹430 Cr₹538 Cr₹358 Cr₹348 Cr₹356 Cr₹321 Cr₹306 Cr₹493 Cr₹702 Cr₹895 Cr₹902 Cr₹606 Cr₹557 Cr₹502 Cr₹471 Cr₹520 Cr₹492 Cr₹388 Cr
EPS28.3121.9825.9720.4924.9322.219.216.220.2513.513.1113.4112.0911.5618.626.4433.733.9922.8420.9918.9117.7319.5718.5414.62
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹9,712 Cr₹8,184 Cr₹8,112 Cr₹9,074 Cr₹7,032 Cr₹5,584 Cr
EBITDA₹2,918 Cr₹2,166 Cr₹2,369 Cr₹3,684 Cr₹2,667 Cr₹1,826 Cr
Net Profit₹2,191 Cr₹1,600 Cr₹1,823 Cr₹2,960 Cr₹1,984 Cr₹1,377 Cr
EPS82.5360.2768.69111.5274.7551.85
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹16,932 Cr₹15,470 Cr₹14,439 Cr₹13,375 Cr₹10,774 Cr₹8,536 Cr
Total Liabilities₹1,963 Cr₹1,899 Cr₹1,672 Cr₹1,647 Cr₹1,479 Cr₹1,226 Cr
Equity₹14,969 Cr₹13,571 Cr₹12,767 Cr₹11,728 Cr₹9,295 Cr₹7,310 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹2,477 Cr₹1,637 Cr₹2,932 Cr₹2,553 Cr₹2,591 Cr₹1,661 Cr
Investing₹-804 Cr₹-269 Cr₹-2,708 Cr₹-2,195 Cr₹75 Cr₹-83 Cr
Financing₹-799 Cr₹-799 Cr₹-797 Cr₹-532 Cr₹-35 Cr₹-1,091 Cr
Free Cash Flow₹2,477 Cr₹1,637 Cr₹2,932 Cr₹2,553 Cr₹2,591 Cr₹1,661 Cr
Shareholding
Promoter 51.88% Institutions 39.51% Public 8.6%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search